Cargando…

Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach

BACKGROUND: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact on the underuse of antithrombotic therapy reported in this population. DISCUSSION: All patients aged ≥75 years with AF have an individual yearly risk of stroke >4 %. However, the risk of hemorrhage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suárez Fernández, Carmen, Formiga, Francesc, Camafort, Miguel, Cepeda Rodrigo, Jose María, Díez-Manglano, Jesús, Pose Reino, Antonio, Tiberio, Gregorio, Mostaza, Jose María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632329/ https://www.ncbi.nlm.nih.gov/pubmed/26530138 http://dx.doi.org/10.1186/s12872-015-0137-7

Ejemplares similares

Erratum: Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
por: Fernández, Carmen Suárez, et al.
Publicado: (2015)

Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
por: Mostaza, Jose María, et al.
Publicado: (2021)

Clinical characteristics and type of antithrombotic treatment in a Spanish cohort of elderly patients with atrial fibrillation according to dependency, frailty and cognitive impairment
por: Mostaza, Jose María, et al.
Publicado: (2018)

Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine
por: Gómez-Huelgas, Ricardo, et al.
Publicado: (2014)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
por: Fenwick, Elisabeth, et al.
Publicado: (2006)

Oral Anticoagulant Use and Appropriateness in Elderly Patients with Atrial Fibrillation in Complex Clinical Conditions: ACONVENIENCE Study
por: Bonanad, Clara, et al.
Publicado: (2022)

Atrial fibrillation as a new prognosis factor in chronic patients after hospitalization: the CHRONIBERIA index
por: Suarez-Dono, Javier, et al.
Publicado: (2023)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Guo, Yutao, et al.
Publicado: (2010)

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
por: Xiang, Wei, et al.
Publicado: (2015)

Atrial fibrillation in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2019)

Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
por: Ehrlinder, Hanne, et al.
Publicado: (2022)

The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

An open debate about the object and purpose of global health knowledge in the context of an interdisciplinary research partnership on HIV/STI prevention priorities in Peru
por: Suarez, Eliana Barrios, et al.
Publicado: (2014)

Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice
por: Sabir, Ian N, et al.
Publicado: (2013)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2022)

To What Extent Is Long-term Care Representative of Elderly Care? A Case Study of Elderly Care Financing in Lombardy, Italy
por: Brenna, Elenka, et al.
Publicado: (2017)

Enhancing second-order empathy in medical practice by supplementing patients’ narratives with certainties
por: Ariso, José María
Publicado: (2018)

Are we ready for artificial intelligence health monitoring in elder care?
por: Ho, Anita
Publicado: (2020)

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
por: Falco, Luigi, et al.
Publicado: (2023)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Health economics: the start of clinical freedom
por: Sacristán, José Antonio, et al.
Publicado: (2010)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ovd1e3f19luhcp4rotl8ga7bdv